Cervicitis

Introduction and Definition of Cervicitis

Cervicitis is an inflammation of the uterine cervix, the lower cylindrical portion of the uterus that projects into the vagina. This condition primarily involves the columnar epithelium of the endocervical canal, though the squamous epithelium of the ectocervix may also be affected. It is broadly categorized into acute and chronic forms. Acute cervicitis is usually infectious and presents with sudden, prominent inflammation and purulent discharge. Chronic cervicitis involves a long-standing inflammatory infiltrate of lymphocytes and plasma cells, often persisting even after the resolution of an acute infection or resulting from non-infectious mechanical and chemical irritants.

Etiology and Common Causative Pathogens

The etiology of cervicitis spans infectious microorganisms and non-infectious agents. Sexually transmitted infections represent the vast majority of infectious cases.

• Chlamydia trachomatis: An obligate intracellular bacterium frequently responsible for asymptomatic or mildly symptomatic mucopurulent infections.
• Neisseria gonorrhoeae: A gram-negative diplococcus causing acute inflammation with conspicuous purulent exudate.
• Trichomonas vaginalis: A flagellated protozoan that can cause diffuse cervicovaginal inflammation.
• Herpes Simplex Virus: Can cause painful ulcerative lesions directly on the cervical epithelium.
• Non-infectious triggers: Exposure to latex condoms, spermicides, contraceptive diaphragms, or feminine hygiene douches can provoke chemical irritation.

Pathophysiology and Clinical Manifestations

When pathogens invade the single layer of columnar epithelial cells lining the endocervical canal, the local immune system mounts an inflammatory response. Increased vascular permeability, neutrophil migration, and localized tissue edema ensue. This process transforms the delicate tissue into a fragile, hyperemic area that bleeds easily.

Patients often experience symptoms that vary from completely asymptomatic presentation to overt discomfort. Key manifestations include:

• Mucopurulent vaginal discharge ranging from yellow to green.
• Intermenstrual bleeding or post-coital spotting due to friable cervical tissue.
• Dyspareunia resulting from deep pelvic friction against inflamed structures.
• Mild lower abdominal discomfort or dysuria if urethral involvement coexists.

Nursing Assessment and Diagnostic Evaluation

Thorough nursing assessment involves gathering a detailed sexual history, menstrual history, and a description of current symptoms like discharge or bleeding patterns. During the speculum examination performed by the clinician, the nurse prepares the equipment and reassures the patient.

Diagnostic confirmation relies on visual inspection and laboratory testing:

• Visual findings: Edema, erythema, and easily induced bleeding from the endocervical mucosa.
• Nucleic Acid Amplification Tests: The gold standard for detecting Chlamydia trachomatis and Neisseria gonorrhoeae from endocervical swabs or urine.
• Wet mount microscopy: Used to identify Trichomonas vaginalis or yeast elements.
• Exclusion of pelvic inflammatory disease: Palpation for uterine tenderness or adnexal pain.

Medical and Pharmacological Management

Treatment strategies focus on eradicating causative pathogens, relieving symptoms, and preventing reinfection or upward spread. Empirical antibiotic therapy is often initiated during initial evaluation if patient compliance is uncertain or STI prevalence is high, pending laboratory results.

• Chlamydial infections: Managed with oral azithromycin or doxycycline.
• Gonococcal infections: Treated with targeted injectable ceftriaxone, frequently combined with azithromycin to cover dual infections and curb resistance.
• Trichomoniasis: Managed using oral metronidazole or tinidazole.
• Partner management: Sexual partners must be evaluated and treated concurrently to prevent immediate ping-pong transmission.

Potential Complications and Nursing Interventions

Untreated cervicitis can allow pathogens to ascend through the internal os into the upper reproductive tract, leading to pelvic inflammatory disease, chronic pelvic pain, ectopic pregnancy, and tubal factor infertility. Pregnant patients face risks of premature rupture of membranes and preterm labor.

Nursing care extends beyond medication administration to holistic support and education:

• Instruct patients to abstain from sexual intercourse until treatment is fully completed and symptoms resolve.
• Emphasize the importance of finishing all prescribed antibiotic courses even if discharge disappears early.
• Counsel on barrier contraceptive methods like male and female condoms to lower future STI acquisition risks.
• Provide a non-judgmental environment to encourage open communication about sexual health.